News

Filter News By

Clear Filters

  1. Cystic Fibrosis Foundation Supports Development of Non-Porcine Enzyme Therapy

    February 12, 2020

    The Cystic Fibrosis Foundation has entered into an agreement with Synspira Therapeutics Inc. to develop a non-porcine enzyme replacement therapy to offer an alternative to people with cystic fibrosis who cannot digest food properly.

  2. Choate Construction Named the Top 2019 National Corporate Team

    January 24, 2020

    Choate Construction's National Corporate Team raised over $670,000 for the Cystic Fibrosis Foundation in 2019, serving as a role model for corporations looking to integrate philanthropy into their business model.

    Topics:

  3. CF Foundation Awards Leading Research Organization Funding to Screen for Potential B. Cepacia Therapy

    January 14, 2020

    The Cystic Fibrosis Foundation awarded nearly $700,000 to Calibr, the drug discovery and development arm of Scripps Research, to screen for a compound that could be used to treat Burkholderia cepacia complex infections.

  4. Circuit Court Rules on ACA in Texas v. United States

    December 19, 2019

    On Dec. 18, the Fifth Circuit Court of the United States issued a decision in Texas v. United States, ruling the individual mandate unconstitutional but sending the case back down to the district court for further review about the fate of the entire Affordable Care Act.

    Topics:

  5. Foundation Announces 2020 Volunteer Leadership Conference Co-Chairs

    December 13, 2019

    Ray Poole and Julie Riedy to lead efforts in Washington, D.C., for volunteer conference, Until CF Stands for Cure Found.

    Topics:

  6. Cystic Fibrosis Foundation Is Exploring New CFTR Modulators

    October 24, 2019

    The Cystic Fibrosis Foundation announced today that it has licensed a compound to the biopharmaceutical company AbbVie to develop into a potential CFTR modulator treatment.
More Posts View All Posts

Related Content

Follow Us On